Exercise Training and Glucose Metabolism in Aging
- Conditions
- Type 2 Diabetes MellitusImpaired Glucose Tolerance (Prediabetes)
- Interventions
- Behavioral: Aerobic exercise trainingBehavioral: Detraining (cessation of exercise)
- Registration Number
- NCT00701051
- Lead Sponsor
- US Department of Veterans Affairs
- Brief Summary
Diabetes and its associated complications affect more than 20 million Americans, and the prevalence of type 2 diabetes and impaired glucose tolerance rises dramatically with age such that 40% of Americans over age 60 are affected. In older adults, glucose metabolism may be affected by reduced skeletal muscle capillary supply, which limits insulin, glucose, and oxygen delivery to skeletal muscle. Reduced capillary supply to skeletal muscle is found in older individuals with impaired glucose tolerance and we hypothesize that this is due to reduced vascular growth factor expression, and chronic inflammation. Further, we hypothesize that reversal of a sedentary lifestyle through aerobic exercise training will increase insulin signaling and vascular growth factor expression, as well as decrease inflammation, to increase capillary supply to skeletal muscle, which contributes to improved glucose metabolism in older adults. This study will: 1) Determine the mechanisms underlying reduced skeletal muscle capillarization in older adults with impaired glucose tolerance; and 2) Determine the effect of aerobic exercise training-induced increases in skeletal muscle capillarization on glucose metabolism in older adults.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- Age 50-75 years
- Non-smoker >2 years
- Body mass index = 18-35 kg/m2
- History of CAD or cerebrovascular disease that would preclude exercise
- Implantable defibrillator
- Active cancer
- Chronic pulmonary, thyroid, renal, liver, or hematological disease
- HIV positive or prone to malnutrition
- Sickle cell anemia
- Type 1 diabetes, or currently on medication to treat type 2 diabetes
- Poorly-controlled type 2 diabetes
- Poorly-controlled hypertension
- Taking medications including: beta-blockers, oral steroids, warfarin, certain statins, hormone replacement therapy (HRT), oral contraceptives (OCP), thiazolidinediones (TZD), or chronic steroids or nonsteroidal analgesics (NSAIDS) that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior)
- Allergic to lidocaine or heparin
- Recent weight change (>5kg in 3 months)
- Currently pregnant or nursing
- Physical impairment limiting exercise
- Dementia or unstable clinical depression
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm 1 Aerobic exercise training Older adults, normal glucose tolerance Arm 1 Detraining (cessation of exercise) Older adults, normal glucose tolerance Arm 2 Aerobic exercise training Older adults, impaired glucose tolerance Arm 2 Detraining (cessation of exercise) Older adults, impaired glucose tolerance
- Primary Outcome Measures
Name Time Method Baseline Glucose Utilization baseline Insulin-stimulated glucose uptake
Glucose Utilization (Pre/Post Intervention) baseline, 24 weeks, 26 weeks Insulin-stimulated glucose uptake
Baseline Skeletal Muscle Capillarization baseline Skeletal Muscle Capillarization (Pre/Post Intervention) baseline, 24 weeks, 26 weeks
- Secondary Outcome Measures
Name Time Method Baseline 2-hour Postprandial Glucose baseline Baseline Cardiorespiratory Fitness baseline maximal oxygen consumption
Cardiorespiratory Fitness baseline, 24 weeks, 26 weeks Maximal oxygen consumption
Body Composition (%Fat) baseline, 24 weeks 2-hr Post-prandial Plasma Glucose Level baseline, 24 weeks, 26 weeks
Trial Locations
- Locations (1)
VA Maryland Health Care System, Baltimore
🇺🇸Baltimore, Maryland, United States